Linking surveillance with action against drug-resistant tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 5, 2012, Pages 399-401

  Cohen, Ted ^a,b   Manjourides, Justin ^c   Hedt Gauthier, Bethany ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Mapping; Multidrug resistant; Surveillance; Survey; Tuberculosis

Indexed keywords

ANALYTIC METHOD; BACTERIAL STRAIN; CLINICAL CLASSIFICATION; CLINICAL DECISION MAKING; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG RESISTANT TUBERCULOSIS; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; QUALITY CONTROL; REINFECTION; REVIEW; SAMPLE SIZE; STANDARDIZATION;

ANTITUBERCULAR AGENTS; DEVELOPING COUNTRIES; HEALTH POLICY; HEALTH SURVEYS; HUMANS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 84865816909     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201203-0394PP     Document Type: Review

References (28)

1. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 1997;24:S121-S130.
2. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 2012;90:111-119.
3. World Health Organization. Global tuberculosis control: WHO report 2011 [accessed 2012 May 5]. WHO/HTM/TB/2011.16. Available from: http://www.who.int/ tb/publications/global-report/en/
4. Espinal M, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baez J, Kochi A, Dye C, Raviglione MC. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000;283:2537-2545. (Pubitemid 30324196)
5. Farmer PE, Kim JY. Community-based approaches to the control of multidrug-resistant tuberculosis: introducing "DOTS- plus". BMJ 1998;317:671-674.
6. Keshavjee S, Farmer PE. Picking up the pace-scale-up of MDR tuberculosis treatment programs. N Engl J Med 2010;363:1781-1784.
7. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis, 4th ed. Geneva, Switzerland: WHO Press. WHO/HTM/TB/2009.422.
8. Cohen T, Colijn C, Wright A, Zignol M, Pym A, Murray M. Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med 2008;177:1302-1306. (Pubitemid 351860906)
9. Waller LA, Gotway CA. Applied spatial statistics for public health data. Hoboken, NJ: Wiley-IEEE, 2004.
10. Jeffery C. Disease mapping and statistical issues in public health surveillance [dissertation]. Harvard University, Cambridge, MA; 2010.
11. Ozonoff A, Webster T, Vieira V, Weinberg J, Ozonoff D, Aschengrau A. Cluster detection methods applied to the Upper Cape Cod cancer data. Environ Health 2005;4:19.
12. Kulldorff M. A spatial scan statistic. Comm Statist Theory Methods 1997; 26:1481-1496. (Pubitemid 127447921)
13. Kelsall JE, Diggle PJ. Non-parametric estimation of spatial variation in relative risk. Stat Med 1995;14:2335-2342.
14. Webster T, Vieira V, Weinberg J, Aschengrau A. Method for mapping population-based case-control studies: an application using generalized additive models. Int J Health Geogr 2006;5:26.
15. Bonetti M, Pagano M. The interpoint distance distribution as a descriptor of point patterns, with an application to spatial disease clustering. Stat Med 2005;24:753-773. (Pubitemid 40298125)
16. Anselin L. Local indicators of spatial association - LISA. Geogr Anal 1995;27:93-115. (Pubitemid 26428654)
17. Getis A, Ord JK. The analysis of spatial association by use of distance statistics. Geogr Anal 1992;24:189-206.
18. Lin H, Shin S, Blaya JA, Zhang Z, Cegielski P, Contreras C, Asencios L, Bayona J, Paciorek CJ, Cohen T. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiol Infect 2010;139:1784-1793.
19. Manjourides J, Lin H, Shin S, Jeffery C, Contreras C, Santa Cruz J, Jave HC, Yagui M, Asencios L, Cohen T. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis (Edinb) 2012;92:273-279.
20. World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Geneva, Switzerland: World Health Organization; 2008. WHO/HTM/TB/2008.394.
21. Cohen T, Colijn C, Finklea B, Wright A, Zignol M, Pym A, Murray M. Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. PLoS ONE 2008;3:e2363.
22. Lemeshow S, Taber S. Lot quality assurance sampling: single- and double-sampling plans. World Health Stat Q 1991;44:115-132.
23. Hedt BL, van Leth F, Zignol M, Cobelens F, van Gemert W, Nhung NV, Lyepshina S, Egwaga S, Cohen T. Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling. Epidemiology 2012;23:293-300.
24. Huong NT, Lan NT, Cobelens FG, Duong BD, Co NV, Bosman MC, Kim SJ, van Soolingen D, Borgdorff MW. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends. J Infect Dis 2006;194:1226-1232. (Pubitemid 44630967)
25. Sar B, Keo C, Leng C, Saman M, Min DC, Chan S, Monchy D, Sarthou JL. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health 2009;40:104-107.
26. Dodge H, Romig H. Sampling inspection tables. Single and double sampling. 2nd ed. New York: John Wiley. 1959.
27. Zignol M, van Gemert W, Falzon D, Jaramillo E, Blanc L, Raviglione M. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis 2011;52:901-906.
28. Boehme CC, Nabeta P, Hilleman D, Nichol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-1015.